Listar por tema "CYP51"
Mostrando ítems 1-9 de 9
-
Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents
| Fecha del documento: 2018 -
Chemical–biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target
| Fecha del documento: 2013 -
CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)
| Fecha del documento: 2017 -
CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffolds
| Fecha del documento: 2012 -
Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets
| Fecha del documento: 2023 -
R‑Configuration of 4‑Aminopyridyl-Based Inhibitors of CYP51 Confers Superior Efficacy Against Trypanosoma cruzi
| Fecha del documento: 2014